Keywords: HPLC; Chemotherapy-induced nausea and vomiting; CINV; Gingerol; Ginger;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: CINV; Emesis; HRQoL; Direct cost; Indirect cost;
Keywords: CINV; 5HT3 receptor antagonists; Anti-emetic guidelines
Keywords: Glucocorticoids; Dexamethasone; Emesis; CINV; RINV; PONV
Efficacy of NEPA (netupitant/palonosetron) across multiple cycles of chemotherapy in breast cancer patients: A subanalysis from two phase III trials
Keywords: NEPA; CINV; Breast cancer; Antiemetic; Netupitant; Palonosetron;
Safety and efficacy of NEPA, an oral fixed combination of netupitant and palonosetron, in older patients
Keywords: Neurokinin-1 receptor antagonist; Netupitant; 5-Hydroxytryptamine receptor antagonist; Palonosetron; NEPA; CINV; Multiple chemotherapy cycles; Older patients; Moderately emetogenic chemotherapy; Highly emetogenic chemotherapy;
Efficacy of aprepitant for CHOP chemotherapy-induced nausea, vomiting, and anorexia
Keywords: Aprepitant; CHOP chemotherapy; CINV; Substance P; Malignant lymphoma;
Effectiveness of palonosetron in prevention of CHOP induced nausea and vomiting in patients with malignant lymphoma
Keywords: CHOP; CINV; Malignant lymphoma; Palonosetron;
Incidence of chemotherapy-induced nausea and vomiting associated with docetaxel and cyclophosphamide in early breast cancer patients and aprepitant efficacy as salvage therapy. Results from the Spanish Breast Cancer Group/2009-02 study
Keywords: Early breast cancer; Antiemesis; Docetaxel-cyclophosphamide; Aprepitant; CINV;
Transcriptome and selected metabolite analyses reveal points of sugar metabolism in jackfruit (Artocarpus heterophyllus Lam.)
Keywords: AGPase; adenosine diphosphate glucose pyrophosphorylase; AI; acid invertase; CINV; cytoplasmic invertase; COG; clusters of orthologous groups; CWINV; cell wall invertase; CYC-β; lycopene beta-cyclase; Ct; cycle threshold; DAP; day after pollination; FK;
In silico investigation into the interactions between murine 5-HT3 receptor and the principle active compounds of ginger (Zingiber officinale)
Keywords: Ginger; Antiemetic; Gingerol; Shogaols; Chemotherapy induced nausea vomiting; CINV;
Evaluation of palonosetron and dexamethasone with or without aprepitant to prevent carboplatin-induced nausea and vomiting in patients with advanced non-small-cell lung cancer
Keywords: AUC; area under the curve; CINV; chemotherapy-induced nausea and vomiting; ECOG; Eastern Cooperative Oncology Group; HEC; highly emetogenic chemotherapy; 5-HT3; 5-hydroxytryptamine-3; MEC; moderately emetogenic chemotherapy; NK-1; neurokinin-1; NSCLC; non
Mechanisms and latest clinical studies of new NK1 receptor antagonists for chemotherapy-induced nausea and vomiting: Rolapitant and NEPA (netupitant/palonosetron)
Keywords: AE; adverse event; AUC; area under the curve; 5-HT3; serotonin subtype 3; CINV; chemotherapy-induced nausea/vomiting; Cmax; maximum serum concentration; CNS; central nervous system; CR; complete response; CYP; cytochrome P450; ECG; electrocardiogram; FLIE
Identification, biological characterization and pharmacophoric analysis of a new potent and selective NK1 receptor antagonist clinical candidate
Keywords: NK; neurokinin; SP; substance P; GPCR; G protein-coupled receptor; CNS; central nervous system; SAD; social anxiety disorders; CINV; chemotherapy-induced nausea and vomiting; PoC; prove of concept; SAR; structure-activity relationship; CDI; carbonyldiim
Microemulsion as a tool for the transdermal delivery of ondansetron for the treatment of chemotherapy induced nausea and vomiting
Keywords: Ondansetron; CINV; Microemulsion; Transdermal route; In vitro and in vivo studies
Safety and efficacy of a triple antiemetic combination with the NK-1 antagonist aprepitant in highly and moderately emetogenic multiple-day chemotherapy
Keywords: Aprepitant; CINV; Multiple-day chemotherapy; Dexamethasone; Granisetron